Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
113 valent conjugated pneumococcal vaccine----1件: 265
2150 mg GSK1265744B----1件: 265
3300mg Gemcabene1件: Gemcabene---1件: 265
43TC----2件: 265, 325
5600mg Gemcabene1件: Gemcabene---1件: 265
6Abacavir1件: Abacavir2件: D00891 ,
D07057 		--4件: 2, 135, 265, 325
7Abacavir 300mg twice daily1件: Abacavir2件: D00891 ,
D07057 		--1件: 265
8Abacavir sulfate2件: Abacavir,
Sulfate ion		2件: D00891 ,
D07057 		--1件: 265
9Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		4件: D00353 ,
D00413 ,
D00891 ,
D07057 		--1件: 265
10ABC----2件: 265, 325
11Acetate1件: Acetate---43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
12ACETYL- L- CARNITINE1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--1件: 265
13Acetylcarnitine1件: Acetylcarnitine---2件: 2, 265
14Acipimox1件: Acipimox1件: D07190 --2件: 78, 265
15AKCEA-ANGPTL3-LRX----2件: 79, 265
16Amprenavir1件: Amprenavir1件: D00894 --1件: 265
17Antiretroviral/Anti HIV----1件: 265
18Aramchol1件: Aramchol---1件: 265
19Atazanavir1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
20Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		3件: D00427 ,
D01276 ,
D07471 		--1件: 265
21Atazanavir (Reyataz)1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
22Atazanavir/Ritonavir2件: Atazanavir,
Ritonavir		3件: D00427 ,
D01276 ,
D07471 		--1件: 265
23Atorvastatin1件: Atorvastatin3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬18件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
24Atorvastatin Calcium2件: Atorvastatin,
Calcium		3件: D00258 ,
D00887 ,
D07474 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 97, 265
25ATV----1件: 265
26Avandia administration for 6-12 weeks----1件: 265
27AZT----3件: 94, 265, 325
28AZT/3TC----1件: 265
29Baricitinib1件: Baricitinib1件: D10308 2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
30Behavioral: 60-minutes of steady state exercise----1件: 265
31Behavioral: Diet----1件: 265
32Behavioral: Exercise----3件: 6, 265, 299
33Behavioral: Exercise Training----1件: 265
34Berberine1件: Berberine---2件: 97, 265
35BMS-232632----1件: 265
36Caffeine1件: Caffeine2件: D00528 ,
D01453 		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬9件: 2, 6, 13, 21, 46, 78, 96, 97, 265
37Calcium1件: Calcium---30件: 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
38Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--9件: 5, 13, 58, 86, 96, 97, 265, 298, 316
39CD----7件: 6, 13, 46, 51, 96, 97, 265
40CD-4 guided therapy interruption----1件: 265
41Cholic Acid1件: Cholic Acid1件: D10699 1件: NR1H4 💬1件: Bile secretion 💬4件: 20, 234, 265, 310
42CoFactor----3件: 6, 265, 288
43Cofactor supplementation (thiamine, riboflavin, L-carnitine)3件: Levocarnitine,
Riboflavin,
Thiamine		7件: D00050 ,
D01622 ,
D01913 ,
D02030 ,
D02176 ,
D04713 ,
D08580 		--1件: 265
44COMBIVIR1件: Zidovudine1件: D00413 --1件: 265
45Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: D00353 ,
D00413 		--1件: 265
46Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265
47Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--45件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331
48Didanosine1件: Didanosine1件: D00296 --2件: 25, 265
49Different HAART regimens----1件: 265
50DIOSMIN1件: Diosmin1件: D07858 --1件: 265
51Diosminex, 500 mg, tabletki powlekane----1件: 265
52Dolutegravir1件: Dolutegravir1件: D10066 --2件: 2, 265
53Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine		2件: D00353 ,
D10066 		--1件: 265
54Dolutegravir 50 MG1件: Dolutegravir1件: D10066 --1件: 265
55Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]2件: Dolutegravir,
Lamivudine		2件: D00353 ,
D10066 		--1件: 265
56Doravirine1件: Doravirine1件: D10624 --1件: 265
57Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		4件: D00353 ,
D01982 ,
D06074 ,
D10624 		--1件: 265
58Efavirenz1件: Efavirenz1件: D00896 --1件: 265
59Efavirenz (EFV)1件: Efavirenz1件: D00896 --1件: 265
60Emtricitabine1件: Emtricitabine1件: D01199 --4件: 25, 93, 265, 325
61Emtricitabine/tenofovir2件: Emtricitabine,
Tenofovir		2件: D01199 ,
D06074 		--1件: 265
62Enfuvirtide1件: Enfuvirtide1件: D02499 --2件: 25, 265
63Enfuvirtide (T20)1件: Enfuvirtide1件: D02499 --1件: 265
64Fenofibrate1件: Fenofibrate1件: D00565 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬5件: 8, 79, 93, 94, 265
65Gemcabene1件: Gemcabene---2件: 79, 265
66Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265
67Genotropin (human recombinant Growth hormone)1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265
68Glycerine1件: Glycerin1件: D00028 --1件: 265
69Growth hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬13件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299
70Growth Hormone Releasing Hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265
71GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265
72High-carbohdyrate breakfast----1件: 265
73High-dose REGN4461----1件: 265
74Hu Leptin (A-100)1件: Leptin---1件: 265
75Human Growth Hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 78, 187, 193, 265
76Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
77Indinavir1件: Indinavir3件: D00897 ,
D02861 ,
D03833 		--1件: 265
78ISIS 304801----1件: 265
79Kaletra (lopinavir [LPVr])1件: Lopinavir1件: D01425 --1件: 265
80L-Carnitine1件: Levocarnitine3件: D02030 ,
D02176 ,
D04713 		--7件: 13, 86, 96, 97, 265, 298, 316
81L-Lactic acid2件: L-Lactic acid,
Lactic acid		1件: D00111 --1件: 265
82Lactic acid1件: Lactic acid1件: D00111 --2件: 265, 299
83Lamivudine1件: Lamivudine1件: D00353 --7件: 2, 26, 42, 46, 135, 265, 325
84Lamivudine/Zidovudine2件: Lamivudine,
Zidovudine		2件: D00353 ,
D00413 		--1件: 265
85Leptin1件: Leptin---2件: 6, 265
86Lopinavir1件: Lopinavir1件: D01425 --1件: 265
87Lopinavir/Ritonavir2件: Lopinavir,
Ritonavir		2件: D00427 ,
D01425 		--1件: 265
88Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: D00427 ,
D00435 ,
D01425 		--1件: 265
89Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: D00353 ,
D00413 ,
D00427 ,
D01425 		--1件: 265
90Low-Dose REGN4461----1件: 265
91Mecasermin1件: Mecasermin2件: D03297 ,
D04870 		2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299
92Metformin1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬24件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
93METFORMIN HYDROCHLORIDE1件: Metformin2件: D00944 ,
D04966 		2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301
94METRELEPTIN1件: Metreleptin1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
95Metrelpetin----1件: 265
96Monotherapy (Lopinavir/ritonavir)2件: Lopinavir,
Ritonavir		2件: D00427 ,
D01425 		--1件: 265
97Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: D00427 ,
D01425 		--1件: 265
98Myalept1件: Metreleptin1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
99N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265
100Nelfinavir1件: Nelfinavir2件: D00899 ,
D08259 		--3件: 49, 265, 331
101Nelfinavir mesylate1件: Nelfinavir2件: D00899 ,
D08259 		--1件: 265
102Nevirapine1件: Nevirapine1件: D00435 --1件: 265
103Niacin1件: Niacin1件: D00049 --3件: 6, 78, 265
104Non-nucleoside reverse transcriptase inhibitors----1件: 265
105Norvir1件: Ritonavir1件: D00427 --2件: 265, 299
106NucleomaxX----1件: 265
107Nucleoside analogue sparing HAART regimen----1件: 265
108Nucleoside reverse transcriptase inhibitors----1件: 265
109Obeticholic Acid1件: Obeticholic acid1件: D09360 1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296
110Other: Glycerine gel1件: Glycerin1件: D00028 --1件: 265
111Other: Observation----1件: 265
112Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265
113Pioglitazone1件: Pioglitazone2件: D00945 ,
D08378 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
114Pioglitazone or metformin2件: Metformin,
Pioglitazone		4件: D00944 ,
D00945 ,
D04966 ,
D08378 		3件: PPARG,
PRKAA1,
PRKAA2 💬		27件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 265
115Pneumococcal polysaccharide vaccine 23 valent----1件: 265
116POLY-L-LACTIC ACID3件: L-Lactic acid,
Lactic acid,
Poly(lactic acid)		1件: D00111 --1件: 265
117Pravastatin1件: Pravastatin2件: D00893 ,
D08410 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333
118Pravastatin sodium1件: Pravastatin2件: D00893 ,
D08410 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 265
119Prevenar13----2件: 19, 265
120Protease inhibitor----1件: 265
121Protease inhibitors----1件: 265
122R-metHuLeptin1件: Metreleptin1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
123Raltegravir1件: Raltegravir1件: D06676 --4件: 13, 26, 93, 265
124RECOMBINANT HUMAN GROWTH HORMONE1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 78, 193, 265
125Recombinant human growth hormone + rosiglitazone2件: Rosiglitazone,
Somatotropin		3件: D00596 ,
D02691 ,
D08491 		2件: GHR,
PPARG 💬		16件: AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265
126REGN4461----1件: 265
127Reyataz1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
128REYATAZ 150MG 60 CPS BL1件: Atazanavir2件: D01276 ,
D07471 		--1件: 265
129Riboflavin1件: Riboflavin3件: D00050 ,
D01622 ,
D01913 		--8件: 13, 38, 46, 96, 97, 162, 168, 265
130Ritonavir1件: Ritonavir1件: D00427 --3件: 2, 86, 265
131Ritonavir (Norvir)1件: Ritonavir1件: D00427 --1件: 265
132Rosiglitazone1件: Rosiglitazone2件: D00596 ,
D08491 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265
133Rosiglitazone maleate1件: Rosiglitazone2件: D00596 ,
D08491 		1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265
134RTV----1件: 265
135Saquinavir1件: Saquinavir2件: D00429 ,
D01160 		--2件: 86, 265
136Serostim®[somatropin (rDNA origin) for injection]1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265
137Setmelanotide1件: Setmelanotide1件: D11927 1件: MC4R 💬1件: Neuroactive ligand-receptor interaction 💬2件: 202, 265
138Simvastatin1件: Simvastatin1件: D00434 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
139Somatropin1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
140ST200----1件: 265
141Standard continuous antiretroviral therapy----1件: 265
142Stavudine1件: Stavudine1件: D00445 --1件: 265
143Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299
144SUSTIVA1件: Efavirenz1件: D00896 --1件: 265
145TAT4 Gel concentration A----1件: 265
146TAT4 Gel concentration B----1件: 265
147Tenofovir1件: Tenofovir disoproxil1件: D01982 --6件: 2, 13, 25, 93, 265, 325
148Tenofovir DF1件: Tenofovir1件: D06074 --1件: 265
149Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		2件: D01982 ,
D06074 		--2件: 93, 265
150Tenofovir Disoproxil Fumarate2件: Tenofovir,
Tenofovir disoproxil		2件: D01982 ,
D06074 		--1件: 265
151Tesamorelin1件: Tesamorelin1件: D06655 1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬2件: 78, 265
152Tesamorelin (Egrifta)1件: Tesamorelin1件: D06655 1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 265
153Testosterone1件: Testosterone6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬9件: 1, 2, 3, 13, 60, 76, 78, 113, 265
154Testosterone injection1件: Testosterone6件: D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 265
155TH9507----1件: 265
156Thiamine1件: Thiamine1件: D08580 --4件: 8, 13, 93, 265
157Tipranavir1件: Tipranavir2件: D03843 ,
D08605 		--1件: 265
158Total Dietary Replacement----1件: 265
159TRUVADA1件: Emtricitabine1件: D01199 --1件: 265
160Use of lipid-lowering drugs.----1件: 265
161Venus Versa----1件: 265
162Viral load driven treatment interruption----1件: 265
163Volanesorsen1件: Volanesorsen1件: D11648 1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265
164VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide1件: Volanesorsen1件: D11648 1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265
165Zidovudine1件: Zidovudine1件: D00413 --6件: 25, 26, 135, 265, 325, 331